Modulation of GABAergic transmission in the globus pallidus by the synthetic cannabinoid WIN 55,212-2.
Maneuf
Y P
YP
Division of Neuroscience, University of Manchester, United Kingdom.
Crossman
A R
AR
Brotchie
J M
JM
D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D048588:Benzoxazines; D004305:Dose-Response Relationship, Drug; D005917:Globus Pallidus / Q000187:drug effects*; D008297:Male; D009025:Morpholines / Q000494:pharmacology*; D009281:Naphthalenes / Q000494:pharmacology*; D009557:Nipecotic Acids / Q000494:pharmacology; D011392:Proline / Q000031:analogs & derivatives*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013997:Time Factors; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
D000700:Analgesics; D048588:Benzoxazines; D009025:Morpholines; D009281:Naphthalenes; D009557:Nipecotic Acids; C030278:nipecotic acid; D005680:gamma-Aminobutyric Acid; C070417:(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone; D011392:Proline; C010983:homoproline